Relevant Chapters
Textbook chapters most relevant to this particular component on the relevancy of cost utility and cost effectiveness as it relates to non-pharmacological or supplement treatment effectiveness in comparison to Prozac, will highlight in a balanced manner, the cost benefit of both interventions as evidenced by empirical study. Moreover, the side effects of flouxetine such as nausea, anxiety, insomnia, drowsiness, headaches, and loss of appetite should be taken into consideration when discussing the cost benefit to the client. In addition, any balanced discussion on the subject should include discourse with regard to the propensity for antidepressants to cause increased risk of suicidal ideations as compared to intervention via therapy such as rational emotive or cognitive behavioral therapy (Prigatano & Plinskin, 2003).
Summary
Flouxetine, or Prozac continues to be one of the most prescribed antidepressants for those clinically diagnosed with depression. Since its introduction some 20 years ago, Prozac has been prescribed to more than 50 million individuals in the United States and internationally. Prozac is designed to increase the supply of serotonin, a neurotransmitter, to the brain. Notwithstanding, in recent years, scientists, practitioners and scholars have posited non-pharmacological and alternative interventions to the standard of practice. Some argue that not only are non-drug related interventions as effective as pharmacological intervention, specifically Prozac, some combinations of treatment including rational emotive therapy and cognitive behavioral therapy have proven positive interventions both in therapeutic evaluation as well as cost utility and cost effectiveness.
It goes without saying that in order to adhere to the guidelines established by the APA (2002), intervention and treatment must consider all aspects of effectiveness including that of cost and benefit to the client.
Bibliography
American Psychiatric Association. (2000). APA practice guidelines for major depressive disorder (2nd ed.). Washington, DC: Author.
Antonuccio, D., Danton, W., & DeNelsky, G. (1995). Psychotherapy vs. medication for Depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 6, 574-585.
Chambless, D., & Hollon, S. (1988). Defining empirically supported therapies. Journal of Consulting and Clinical Psychology, 66, 7-18.
Hunsley, J. (2003). Cost-effectiveness and medical cost offset considerations in psychological service provision. Canadian Psychology, 44, 61-73.
Olfson, M., & Klelrman, G. (1993). Trends in the prescription of anti-depressants by office-based psychiatrists. American Journal of Psychiatry, 150, 571-577.
Petersen, T., Pava, J., Buchin, J., Matthews, J., Papakostas, G., et al. (2007). The role of cognitive-behavioral therapy and flouxetine in prevention of recurrence of major depressive disorder. Cognitive Therapy Research, 34, 13-23.
Prigatano, P., Rosen, A., Herman, R., Olchanski, N., & Neumann, P. (2004). Cost-utility
Analysis studies of depression management: a systematic review. American Journal of Psychiatry, 181, 2155-2162.
Prigatano, G., & Plinskin, N. (2003). Postscript: reflections and future directions. In G.
Prigatano & N.H. Pliskin, (Eds.), Clinical neuropsychology and cost outcome research:A beginning (pp. 433-447). New York: Psychology Press.
Revicki, D., Siddique, J., Frank, L., Chung, J., Green, B., Krupnick, J., et al. (2005).
Cost effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women. Archives of General Psychiatry, 62, 868-875.
Sava, F., Yates, B., Lupu, V., Szentagotai, A., & David, D. (2009). Cost effectiveness and cost utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine in treating depression: a randomized clinical trial. Journal of Clinical Psychology, 65(1), 36-52.
Schulberg, H., Raue, P., & Rollman, B. (2002). The effectiveness of psychotherapy in treating depressive disorders in primary care practice: Clinical and cost perspectives. General Hospital Psychiatry, 24, 203-212.
Scott, J., Palmer, S., Paykel, E., Teasdale, J., & Hayhurst, H. (2003). Use of…
Direct to Consumer Advertising HISTORY OF DRUG ADVERTISING THE DTC ADVERTISING PHENOMENON CREATING DEMAND DECEPTIVE ADVERTISING - A WOLF IN SHEEP'S CLOTHING CAUSE OF DEATH PROFIT UTILIZATION, PRICING, AND DEMOGRAPHICS LEGISLATION, POLITICS AND PATENTS LEGISLATIVE INITIATIVES REGARDING DTC RECALLED and/or DEADLY DRUGS In order to provide the most efficient method of evaluation, the study will utilize existing stores of qualitative and quantitative data from reliable sources, such as U.S. Government statistical references, University studies, and the studies and publications of non-profit
Treatment of Psychological Disorders The patient is a 46-year-old man who is experiencing difficulties at work to which he attributes the symptoms he is experiencing. Presenting symptoms include feelings of depression, difficulty sleeping, loss of appetite, difficulty concentrating, anxiety, and three episodes of panic-attack. The patient's wife is very worried about her husband and reports that their communication is practically non-existent over the past three weeks. Schema for Diagnosis, Treatment, and
Alzheimer's Disease The author of this report has been asked to lay out a "well-orchestrated" approach to treating someone that is living with Alzheimer's disease. As would be the case with many to most disorders, there are both lifestyle measures as well as pharmacological methods that could and should be used when it comes to the treatment of Alzheimer's. There is no cure for Alzheimer's. Even so, the medical field is
Chocolate: Behind Its Bad Rap In today's society, chocolate is everywhere. It seems that people have developed a love-hate relationship with chocolate. According to the U.S. Department of Commerce, in 1997, the average American ate 11.7 pounds of chocolate. American adults ranked chocolate as the most-craved food and as their favorite flavor by a three-to-one margin. (Mustad, 2001) Throughout the world, exists a society of chocolate lovers. While Americans consume, on average,
Substance abuse can be defined simply as a maladaptive use of any harmful substance for the purposes of mood-altering and not limited to the use of prohibited drugs or the misuse of prescription and over-the-counter drugs with an intention other than that for which it is recommended or in a way or in quantities other than instructed (Bennett & Holloway, 2005). Drug related crimes are brutal criminal acts that are committed
Discussion Though a great deal more is known about neurotransmission today than was known at the beginning of the research associated with the initial biological discoveries of neurotransmitters and the neurotransmission process there is still a great deal to be discovered. Neurotransmission disorganization and impairment is clearly identified as a pervasive aspect of many psychological disorders. This is particularly true of the anxiety disorders and OCD. There is no doubt that
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now